Live tape
Top 8, mentions 7d10,088GOOGL1,953 mentions▲ +0.04SNDK1,580 mentions▲ +0.11NVDA1,211 mentions▲ +0.08META1,184 mentions▲ +0.03MRNA1,163 mentions▲ +0.09SPCX1,123 mentions▲ +0.09NBIS1,003 mentions▲ +0.09HTZ871 mentions▲ +0.09

Equity · Healthcare

CRNX

Crinetics Pharmaceuticals, Inc. · NasdaqGS

$84.02 +0.02% 1D Finazon · prior-day close · Aug 5, 2026
Price · Chart
Our own end-of-day closes 52 sessions
$100 $20 21 May 5 Aug

The line runs $37 on 21 May through $84.02 on 5 August, on a scale from $20 to $100. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView

The chart above plots the price of CRNX over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 52 sessions over that window: $37 on 21 May 2026 through $84.02 on 5 August 2026.

Market cap $8.9B
52-week range $26.85 – $84.02
Avg volume 1.1M

Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Aug 19, 2026

CRNX insider trades

SEC Form 4 · last 90 days · newest reported trade 2 Jul 2026
Open-market buys 0
Open-market sells 2
Net sold $366K
Non-trade filings 9
Date Insider Type Shares Value
02 Jul 2026 Vivaldi Coelho Rogerio Director Sell 3,000 $120K
17 Jun 2026 Okey Stephanie Director Sell 6,900 $246K

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
07 Aug 2026 Struthers Richard Scott President & CEO Option exercise 19,928 $400K
18 Jun 2026 Bedrosian Camille L Director Award 5,925
18 Jun 2026 Okey Stephanie Director Award 5,925
18 Jun 2026 WIERENGA WENDELL Director Award 5,925
18 Jun 2026 Vivaldi Coelho Rogerio Director Award 5,925
18 Jun 2026 Nichols Weston Director Award 5,925
18 Jun 2026 Fust Matthew K Director Award 5,925
18 Jun 2026 Deardorf Caren Director Award 5,925
29 May 2026 Struthers Richard Scott President & CEO Gift 413,300

CRNX reported financials

SEC EDGAR XBRL

CRNX reported revenue of $7.7M for the fiscal year ended 31 Dec 2025. Net income over the same period was −$465.3M.

Figure Reported Period
Revenue $7.7M 31 Dec 2025 fiscal year
Net income −$465.3M 31 Dec 2025 fiscal year
Diluted EPS −$4.95 31 Dec 2025 fiscal year
Total assets $1.3B 30 Jun 2026 at period end
Total equity $1.2B 30 Jun 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026

CRNX earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q2 2026 $-1.14 —
31 Mar 2026 Q1 2026 $-1.23 —
31 Dec 2025 FY 2025 $-4.95 —
30 Sep 2025 Q3 2025 $-1.38 —
30 Jun 2025 Q2 2025 $-1.23 $1M
31 Mar 2025 Q1 2025 $-1.04 $0M
31 Dec 2024 FY 2024 $-3.69 $1M
30 Sep 2024 Q3 2024 $-0.96 —

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

CRNX institutional holders

SEC Form 13F

7 of the 45 institutional funds we track reported a CRNX position for the quarter ended 30 Jun 2026 — a combined $170.4M; the latest of those filings landed 14 Aug 2026.

Fund Action Shares Value
Baker Bros. Advisors Held (±25%) 2,351,465 $88.0M
Marshall Wace Added +64.7% shares 1,126,639 $42.2M
Fisher Asset Management Held (±25%) −2.8% shares 741,553 $27.7M
Citadel Advisors Trimmed −56.5% shares 138,329 $5.2M
Two Sigma Investments Held (±25%) 87,299 $3.3M
Man Group Added +28.3% shares 61,043 $2.3M
Point72 Asset Management New position 46,381 $1.7M
Millennium Management Exited
Tudor Investment Corp Exited

Source: SEC EDGAR 13F filings

CRNX fails-to-deliver

SEC CNS data

On 22 Jul 2026, 145 shares of CRNX failed to deliver (about $12K).

Settlement date Shares failed Notional % of shares out
22 Jul 2026 145 $12K <0.001%
14 Jul 2026 292,982 $24.5M 0.276%
13 Jul 2026 79 $7K <0.001%
09 Jul 2026 3,999 $334K 0.004%
07 Jul 2026 73,728 $3.1M 0.070%
06 Jul 2026 900 $38K 0.001%

Source: SEC fails-to-deliver (CNS) data

Congressional trades in CRNX

STOCK Act disclosures

The most recent congressional trade disclosed in CRNX is a purchase by Gilbert Ray Cisneros, Jr. (house, CA), dated 03 Mar 2026.

Date Member Type Amount
03 Mar 2026 filed 07 Apr 2026 Gilbert Ray Cisneros, Jr. house · Democrat–CA Purchase $1K–$15K

Source: U.S. House of Representatives financial disclosures